Dirk W. Kirsten
Director of Finance/CFO bij MEDARTIS HOLDING AG
Vermogen: 146 601 $ op 31-03-2024
Profiel
Dirk W.
Kirsten is currently the Chief Financial Officer at Medartis Holding AG since 2021.
Previously, he worked as the Head-Group Funding & Capital Markets at Roche Holding AG from 2002 to 2004, as the Group Treasurer at Syngenta AG from 2004 to 2008, and as the Chief Financial Officer at Nobel Biocare Holding AG from 2008 to 2013.
He holds a doctorate degree from Universität zu Köln.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
MEDARTIS HOLDING AG
0.01% | 31-12-2022 | 1 477 ( 0.01% ) | 146 601 $ | 31-03-2024 |
Actieve functies van Dirk W. Kirsten
| Bedrijven | Functie | Begin |
|---|---|---|
| MEDARTIS HOLDING AG | Director of Finance/CFO | 01-03-2021 |
Eerdere bekende functies van Dirk W. Kirsten
| Bedrijven | Functie | Einde |
|---|---|---|
| NOBEL BIOCARE HOLDING AG | Director of Finance/CFO | 01-01-2013 |
| SYNGENTA | Treasurer | 01-01-2008 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01-01-2004 |
Opleiding van Dirk W. Kirsten
| Universität zu Köln | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| ROCHE HOLDING AG | Health Technology |
| MEDARTIS HOLDING AG | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Syngenta AG
 Syngenta AG Chemicals: AgriculturalProcess Industries Syngenta AG specializes in crop protection and seeds production. Its products include selective and non-selective herbicides, fungicides, insecticides, as well as field crop and vegetable seeds. The company was founded on November 12, 1999 and is headquartered in Basel, Switzerland. | Process Industries |
Nobel Biocare Holding AG
 Nobel Biocare Holding AG Medical SpecialtiesHealth Technology Nobel Biocare Holding AG is a provider in the field of innovative implant-based dental restorations - from single-tooth to fully edentulous indications. It offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems as well as diagnostics, treatment planning, guided surgery solutions and biomaterials. The company's portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems, a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning and guided surgery solutions and biomaterials. Nobel Biocare Holding was founded in 1981 and is headquartered in Kloten, Switzerland. | Health Technology |
